Related Experiment Video
Updated: Dec 27, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Knockdown of microRNA-181a inhibits osteosarcoma cells growth and invasion through triggering NLRP3-dependent
1Department of Orthopedics, Wuxi traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Wuxi, Jiangsu, China. zhiyan021939264@163.com.
Objective:
This study aimed to investigate the physiological function and molecular mechanism of microRNA-181a (miRNA-181a) in the carcinogenesis of osteosarcoma.
Materials And Methods:
The relative expression of miRNA-181a in tissues and cultured cells was detected by quantitative real time-polymerase chain reaction (qRT-PCR). MiR-181a inhibitor and miR-181a mimics were used to manipulate its level in cells. Cell proliferation and invasion were measured using Cell Counting Kit-8 (CCK-8) assay and transwell assay, respectively. The protein levels of the targeted genes were detected by Western blotting and immunohistochemistry. Terminal Deoxynucleotidyl Transferase (TdT)-mediated dUTP Nick-End Labeling (TUNEL) assay was employed to detect cell apoptosis. Moreover, a xenograft tumor bearing mice model was used to evaluate the effect of miR-181a in vivo.
Results:
We found that miRNA-181a was aberrantly elevated in osteosarcoma tissues and cells. Moreover, the overexpression of miRNA-181a could facilitate cell proliferation and migration. By contrast, miRNA-181a knockdown reverses these effects. Additionally, downregulation of miRNA-181a could activate NOD-like receptor protein 3 (NLRP3)-dependent pyroptosis, as evidenced by the increase of pyroptosis-related genes (NLRP3, caspase-1, interleukin-18, and interleukin-1β) in miRNA-181a inhibitor transfected cells compared with the control. Further mechanistic studies identified that miRNA-181a knockdown suppresses cell proliferation and invasion by activating NLRP3-dependent pyroptosis. Silencing NLRP3 could effectively reverse the effects mediated by miRNA-181a inhibitor. Consistently, in vitro results also demonstrated that blockade of miRNA-181a notably suppresses tumor growth via activating pyroptosis.
Conclusions:
These results provide that miRNA-181a might serve as potential therapeutic target for osteosarcoma patients.
Insights
MicroRNA-181a (miRNA-181a) is elevated in osteosarcoma, promoting cancer progression. Inhibiting miRNA-181a activates pyroptosis, offering a potential therapeutic strategy for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is a primary bone malignancy with limited effective treatments.
- MicroRNAs play crucial roles in cancer development and progression.
- The specific role of microRNA-181a (miRNA-181a) in osteosarcoma pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the physiological function of miRNA-181a in osteosarcoma.
- To elucidate the molecular mechanisms underlying miRNA-181a's role in osteosarcoma carcinogenesis.
- To evaluate miRNA-181a as a potential therapeutic target for osteosarcoma.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) to measure miRNA-181a expression.
- In vitro assays (Cell Counting Kit-8, transwell, Western blotting, TUNEL) to assess cell proliferation, invasion, apoptosis, and protein levels.
- In vivo studies using a xenograft tumor model in mice to evaluate therapeutic effects.
- Manipulation of miRNA-181a levels using inhibitors and mimics.
Main Results:
- miRNA-181a was significantly upregulated in osteosarcoma tissues and cells.
- Overexpression of miRNA-181a promoted cell proliferation and migration, while knockdown inhibited these processes.
- Downregulation of miRNA-181a induced NOD-like receptor protein 3 (NLRP3)-dependent pyroptosis, suppressing tumor growth in vitro and in vivo.
- Silencing NLRP3 reversed the effects of miRNA-181a inhibition.
Conclusions:
- miRNA-181a plays a pro-carcinogenic role in osteosarcoma by promoting proliferation and migration.
- miRNA-181a functions by suppressing NLRP3-dependent pyroptosis.
- Targeting miRNA-181a represents a promising therapeutic strategy for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi

